BridgeMD
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy
EU CTIS ID: 2023-508813-18-00
What this study is testing
To evaluate the safety and tolerability of BHV-7000
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. Subjects who completed the double-blind phase (DBP) of prior parent study, BHV7000-302 or BHV7000-303.
- 2. Females of childbearing potential (FOCBP) must have a negative urine pregnancy test at the Baseline/Day 0 visit.
You likely can't join if
- 1. Any condition, such as an ongoing AE with/without sequalae, or is poorly tolerating IP in the DBP of the parent study, that would interfere with the subject’s ability to comply with study instructions, place the subject at unacceptable risk, and/or confound the interpretation of safety or efficacy data from the study, as judged by the Investigator.
- 2. Any medical condition, based on the judgement of the Investigator, that would confound the ability to adequately assess safety and efficacy outcome measures.
The study team makes the final eligibility decision.
Where it's taking place
- Mexico
- United Kingdom
- United States
- Argentina
- Chile
- Switzerland
- South Africa
- Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mexico; United Kingdom; United States; Argentina; Chile; Switzerland and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.